Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02399371
Brief Title: Pembrolizumab in Treating Patients With Malignant Mesothelioma

First Submitted : March 13, 2015
First Submitted that Met QC Criteria : March 20, 2015
First Posted : March 26, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : March 1, 2018
Last Update Posted : March 5, 2018